V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300003246 | 300002264 | null | 55.5 | Disease modification (D) | 2015-04-16 | 2015-07-22 | Capecitabine | N | N | 300014993 | CAPECITABINE |
| 300003248 | 300002265 | 1.55 | 86.4 | Neo-adjuvant (N) | 2016-02-26 | 2016-03-04 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 300015001 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003249 | 300002266 | null | 82.1 | Curative (C) | 2016-02-17 | 2016-03-08 | Cetuximab 7 day (Cycle 1) | 02 | Y | 300015003 | CETUXIMAB |
| 300003250 | 300002267 | 1.74 | 81 | null | 2013-08-02 | 2013-08-13 | Cetuximab + Radiotherapy Maint | 02 | N | 300015004 | CETUXIMAB + RT |
| 300003251 | 300002267 | 1.7 | 90.9 | Curative (C) | 2014-02-07 | 2014-02-14 | Cetuximab 7 day (Cycle 1) | N | N | 300015004 | CETUXIMAB |
| 300003252 | 300002268 | 1.87 | null | null | 2014-03-06 | 2014-03-10 | CETUXIMAB + RT | N | null | 300015007 | CETUXIMAB + RT |
| 300003253 | 300002268 | 1.75 | 64 | Curative (C) | 2014-01-27 | 2014-02-03 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300015007 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003258 | 300002271 | 1.8 | 76.7 | Adjuvant (A) | 2014-08-31 | 2014-09-02 | Capecitabine | 2 | N | 300015025 | CAPECITABINE |
| 300003259 | 300002271 | 1.62 | 82 | Neo-adjuvant (N) | 2013-09-24 | 2013-09-26 | CISPLATIN + FLUOROURACIL | 02 | null | 300015025 | CISPLATIN + FLUOROURACIL |
| 300003260 | 300002272 | 1.72 | 64 | Palliative (P) | 2017-02-18 | 2017-02-26 | CARBOPLATIN + PACLITAXEL | N | Y | 300015035 | CARBOPLATIN + PACLITAXEL |
| 300003261 | 300002273 | null | 117 | Curative (C) | 2014-02-23 | 2014-03-03 | Carboplatin + Paclitaxel (3 weekly) | N | N | 300015037 | CARBOPLATIN + PACLITAXEL |
| 300003262 | 300002274 | 1.84 | 72.4 | Adjuvant (A) | 2013-12-09 | 2013-12-26 | Cetuximab 7 day (Cycle 1) | N | Y | 300015039 | CETUXIMAB |
| 300003263 | 300002275 | 1.65 | 68.4 | Neo-adjuvant (N) | 2014-11-09 | 2014-11-11 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300015041 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003264 | 300002275 | 1.7 | 50.6 | Palliative (P) | 2014-04-24 | 2014-05-14 | Carboplatin + Paclitaxel (3 weekly) | N | N | 300015041 | CARBOPLATIN + PACLITAXEL |
| 300003265 | 300002276 | 1.81 | 56.3 | null | 2015-03-27 | 2015-04-14 | Cisplatin +Fluorouracil (3 wk) | null | N | 300015046 | CISPLATIN + FLUOROURACIL |
| 300003266 | 300002277 | 1.55 | 86.9 | null | 2017-03-18 | 2017-03-23 | Cetuximab + Radiotherapy Maint | Y | Y | 300015051 | CETUXIMAB + RT |
| 300003267 | 300002278 | 1.64 | 71.9 | Curative (C) | 2014-08-17 | 2014-08-27 | CETUXIMAB | N | Y | 300015052 | CETUXIMAB |
| 300003268 | 300002278 | 1.6 | 85.5 | Curative (C) | 2013-06-19 | 2013-06-23 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300015052 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003269 | 300002279 | 1.5 | 58.4 | Not known (9) | 2014-12-03 | 2014-12-09 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 300015060 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003270 | 300002280 | 1.62 | null | Neo-adjuvant (N) | 2017-04-30 | 2017-05-07 | CISPLATIN + FLUOROURACIL | N | N | 300015067 | CISPLATIN + FLUOROURACIL |
| 300003271 | 300002281 | 1.7 | 85.6 | Neo-adjuvant (N) | 2014-11-07 | 2014-11-14 | Cisplatin +Fluorouracil (3 wk) | 2 | N | 300015070 | CISPLATIN + FLUOROURACIL |
| 300003272 | 300002282 | 1.7 | 65 | Curative (C) | 2015-10-10 | 2015-10-24 | Cetuximab 7 day (Cycle 1) | 02 | Y | 300015072 | CETUXIMAB |
| 300003273 | 300002282 | 1.65 | 34 | Curative (C) | 2017-11-21 | 2017-11-26 | Cetuximab 7 day (Cycle 1) | N | Y | 300015072 | CETUXIMAB |
| 300003274 | 300002283 | 1.8 | 82.2 | Curative (C) | 2015-09-27 | 2015-10-06 | Cetuximab + Radiotherapy Load | 2 | Y | 300015077 | CETUXIMAB + RT |
| 300003275 | 300002283 | 1.69 | null | Adjuvant (A) | 2017-04-19 | 2017-04-20 | Capecitabine | Y | N | 300015077 | CAPECITABINE |
| 300003276 | 300002284 | null | 61.75 | null | 2017-01-12 | 2017-01-14 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300015086 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003277 | 300002284 | null | null | null | null | 2013-03-10 | Cisplatin +Fluorouracil (3 wk) | Y | N | 300015086 | CISPLATIN + FLUOROURACIL |
| 300003278 | 300002285 | null | 109.7 | Curative (C) | 2017-10-27 | 2017-11-11 | Trial Unspecified | null | Y | 300015089 | TRIAL |
| 300003279 | 300002286 | 1.63 | 105 | Curative (C) | 2015-01-19 | 2015-02-24 | Cetuximab 7 day (Cycle 1) | N | Y | 300015094 | CETUXIMAB |
| 300003280 | 300002286 | 1.64 | 72.3 | Palliative (P) | 2013-10-07 | 2013-10-07 | Cisplatin +Fluorouracil (2 wk) | null | null | 300015094 | CISPLATIN + FLUOROURACIL |
| 300003281 | 300002287 | 1.61 | 80 | Curative (C) | 2013-06-23 | 2013-07-07 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300015099 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003282 | 300002288 | 1.86 | 84.1 | Adjuvant (A) | 2018-03-10 | 2018-03-24 | Capecitabine | N | N | 300015101 | CAPECITABINE |
| 300003283 | 300002288 | 1.52 | 125 | Palliative (P) | null | 2016-04-28 | CISPLATIN + FLUOROURACIL | N | N | 300015101 | CISPLATIN + FLUOROURACIL |
| 300003284 | 300002289 | 1.58 | 62.3 | Curative (C) | 2016-10-04 | 2016-10-09 | Cetuximab + Radiotherapy Maint | N | Y | 300015108 | CETUXIMAB + RT |
| 300003285 | 300002290 | 1.8 | 80.7 | Adjuvant (A) | 2017-04-07 | 2017-04-08 | Capecitabine | N | N | 300015109 | CAPECITABINE |
| 300003286 | 300002290 | null | 57 | null | 2014-06-20 | 2014-07-05 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300015109 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003288 | 300002292 | null | 61 | Neo-adjuvant (N) | 2017-03-08 | 2017-03-17 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300015119 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003289 | 300002293 | 1.67 | 43 | Adjuvant (A) | 2013-11-09 | 2014-02-21 | Capecitabine | N | N | 300015120 | CAPECITABINE |
| 300003290 | 300002294 | 1.43 | null | Not known (9) | 2014-05-22 | 2014-05-27 | CETUXIMAB + RT | 02 | Y | 300015122 | CETUXIMAB + RT |
| 300003291 | 300005906 | 1.5 | 98.8 | Neo-adjuvant (N) | 2013-03-19 | 2013-04-08 | Cisplatin +Fluorouracil (3 wk) | N | Y | 300015127 | CISPLATIN + FLUOROURACIL |
| 300003293 | 300002296 | 1.69 | 82.5 | null | 2016-04-30 | 2016-05-07 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300015133 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003294 | 300005907 | 1.57 | 83 | Curative (C) | 2013-09-30 | 2013-10-18 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300015142 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003295 | 300002297 | 1.78 | 53.4 | Neo-adjuvant (N) | 2014-01-19 | 2014-01-28 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 300015152 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003296 | 300002298 | 1.53 | 84.6 | Curative (C) | 2015-05-14 | 2015-05-16 | CARBOPLATIN + PACLITAXEL | 2 | N | 300015156 | CARBOPLATIN + PACLITAXEL |
| 300003297 | 300002299 | 1.52 | 57.8 | Neo-adjuvant (N) | 2014-05-06 | 2014-05-20 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300015157 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003298 | 300005908 | 1.47 | 85.5 | Neo-adjuvant (N) | 2013-03-08 | 2013-03-10 | CISPLATIN + FLUOROURACIL | 02 | N | 300015158 | CISPLATIN + FLUOROURACIL |
| 300003299 | 300002300 | 1.59 | 77 | Adjuvant (A) | 2016-04-27 | 2016-05-02 | Capecitabine | N | N | 300015159 | CAPECITABINE |
| 300003300 | 300002301 | 1.63 | 72.5 | Neo-adjuvant (N) | 2017-01-12 | 2017-02-08 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 300015173 | CISPLATIN + FLUOROURACIL |
| 300003301 | 300002301 | 1.59 | 87.4 | Neo-adjuvant (N) | 2014-01-22 | 2014-01-31 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 300015173 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003302 | 300002301 | 1.63 | 91 | Palliative (P) | 2016-11-15 | 2016-11-20 | Trial Unspecified | N | N | 300015173 | TRIAL |